Overview

A Trial of SHR - 1906 in Healthy Subjects

Status:
Not yet recruiting

Trial end date:
2022-02-09

Target enrollment:

Participant gender:

Summary

This study is a phase 1 single dose escalation study of SHR-1906 in healthy subjects. The purpose of the study is to evaluate the safety, tolerability and pharmacokinetics of SHR-1906 in healthy subjects.

Phase:

Phase 1

Details

Lead Sponsor:

Guangdong Hengrui Pharmaceutical Co., Ltd